Outcomes in critically ill patients with systemic rheumatic disease: A multicenter study

Chest

Volumn 148, Issue 4, 2015, Pages 927-935

  Dumas, Guillaume ^a   Géri, Guillaume ^c   Montlahuc, Claire ^b   Chemam, Sarah ^d   Dangers, Laurence ^f   Pichereau, Claire ⁱ   Brechot, Nicolas ^f   Duprey, Matthieu ^f   Mayaux, Julien ^g   Schenck, Maleka ^j   Boisramé Helms, Julie ^k   Thomas, Guillemette ^l   Baboi, Loredana ^m   Mouthon, Luc ⁿ   Amoura, Zair ^h   Papo, Thomas ^e   Mahr, Alfred ^a   Chevret, Sylvie ^b   Chiche, Jean Daniel ^c   Azoulay, Elie ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b Biostatistics Department   (France)

^c Institut Cochin   (France)

^d Medical Intensive Care Unit   (France)

^e BICHAT HOSPITAL   (France)

^f Service de Réanimation Médicale   (France)

^g Institut de Cardiologie   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ HÔPITAL SAINT ANTOINE   (France)

^j HÔPITAL DE HAUTEPIERRE   (France)

^k UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^l HÔPITAL NORD   (France)

^m CROIX ROUSSE HOSPITAL   (France)

ⁿ UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE FACTOR; INOTROPIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; COMORBIDITY; CRITICALLY ILL PATIENT; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FRANCE; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; SARCOIDOSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SHOCK; SURVIVAL; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC RHEUMATIC DISEASE; TREATMENT DURATION; CLINICAL TRIAL; CRITICAL ILLNESS; DISEASE MANAGEMENT; EPIDEMIOLOGY; INTENSIVE CARE; INTENSIVE CARE UNIT; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RHEUMATIC DISEASES; SURVIVAL RATE; TRENDS;

ADULT; AGED; CRITICAL CARE; CRITICAL ILLNESS; DISEASE MANAGEMENT; FEMALE; FRANCE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RHEUMATIC DISEASES; SURVIVAL RATE;

EID: 84943397591     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-3098     Document Type: Article

References (38)

1. Fauci Anthony S, Braunwald E. H arrison's Principles of Internal Medicine. 17th ed. New York, NY : McGraw-Hill Medical; 2008.
2. Goldblatt F, O'Neill SG. Clinical aspects of autoimmune rheumatic diseases. Lancet. 2013; 382 (9894): 797-808.
3. Giannakopoulos B, Passam F, Rahgozar S, Krilis SA. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood. 2007; 109 (2): 422-430.
4. Quintero OL, Rojas-Villarraga A, Mantilla RD, Anaya JM. Autoimmune diseases in the intensive care unit. An update. Autoimmun Rev. 2013; 12 (3): 380-395.
5. Janssen NM, Karnad DR, Guntupalli KK. Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome. Crit Care Clin. 2002; 18 (4): 729-748.
6. Godeau B, Mortier E, Roy PM, et al. Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol. 1997; 24 (7): 1317-1323.
7. Lee J, Yim JJ, Yang SC, et al. Outcome of patients with connective tissue disease requiring intensive care for respiratory failure. Rheumatol Int. 2012; 32 (11): 3353-3358.
8. Williams FM, Chinn S, Hughes GR, Leach RM. Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis. 2002; 61 (5): 414-421.
9. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013; 65 (1): 1-11.
10. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet. 1990; 335 (8697): 1078-1080.
11. Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013; 39 (2): 165-228.
12. Ferguson ND, Fan E, Camporota L, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012; 38 (10): 1573-1582.
13. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012 ;2(1):1-138.
14. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012 ;307(23):2526-2533.
15. Afessa B, Tefferi A, Litzow MR, Krowka MJ, Wylam ME, Peters SG. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med. 2002; 166 (5): 641-645.
16. Bradley B, Branley HM, Egan JJ, et al; British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee; Thoracic Society of Australia; New Zealand Thoracic Society; Irish Thoracic Society. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society [published correction appears in Thorax. 2008;63(11):1029]. Thorax. 2008; 63 (suppl 5): v1-v58.
17. Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med. 1990; 113 (5): 352-357.
18. Asherson RA, Cervera R, de Groot PG, et al; Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003; 12 (7): 530-534.
19. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988; 16 (3): 128-140.
20. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011; 30 (4): 377-399.
21. Vesin A, Azoulay E, Ruckly S, et al. Reporting and handling missing values in clinical studies in intensive care units. Intensive Care Med. 2013; 39(8): 1396-1404.
22. Camargo JF, Tobón GJ, Fonseca N, et al. Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus. 2005; 14 (4): 315-320.
23. Thong BY, Tai DY, Goh SK, Johan A. An audit of patients with rheumatic disease requiring medical intensive care. Ann Acad Med Singapore. 2001; 30 (3): 254-259.
24. Moreels M, Mélot C, Leeman M. Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit. Intensive Care Med. 2005; 31 (4): 591-593.
25. Bouachour G, Roy PM, Tirot P, Guerin O, Gouello JP, Alquier P. Prognosis of systemic diseases diagnosed in intensive care units [in French]. Presse Med. 1996; 25(18):837-841.
26. Pourrat O, Bureau JM, Hira M, Martin- Barbaz F, Descamps JM, Robert R. Outcome of patients with systemic rheumatic diseases admitted to intensive care units: a retrospective study of 39 cases [in French]. Rev Med Interne. 2000; 21 (2): 147-151.
27. Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007; 29 (1): 1-9.
28. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003; 2 (3): 119-125.
29. Cruz BA, Ramanoelina J, Mahr A, et al. Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology (Oxford). 2003; 42 (10): 1183-1188.
30. Godeau B, Coutant-Perronne V, Le Thi Huong D, et al. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol. 1994; 21 (2): 246-251.
31. Moosig F, Holle JU, Gross WL. Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence? Arthritis Res Ther. 2009; 11 (5): 253.
32. Hsu CL, Chen KY, Yeh PS, et al. Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study. Crit Care. 2005; 9 (3): R177-R183.
33. Khan SA, Subla MR, Behl D, Specks U, Afessa B. Outcome of patients with small-vessel vasculitis admitted to a medical ICU. Chest. 2007; 131 (4): 972-976.
34. Befort P, Corne P, Filleron T, et al. Prognosis and ICU outcome of systemic vasculitis. BMC Anesthesiol. 2013; 13 (1): 27.
35. Holguin F, Ramadan B, Gal AA, Roman J. Prognostic factors for hospital mortality and ICU admission in patients with ANCA-related pulmonary vasculitis. Am J Med Sci. 2008; 336 (4): 321-326.
36. Godeau B, Boudjadja A, Dhainaut JF, et al. Outcome of patients with systemic rheumatic disease admitted to medical intensive care units. Ann Rheum Dis. 1992; 51 (5): 627-631.
37. Faguer S, Ciroldi M, Mariotte E, et al. Prognostic contributions of the underlying inflammatory disease and acute organ dysfunction in critically ill patients with systemic rheumatic diseases. Eur J Intern Med. 2013; 24 (3): e40-e44.
38. Schneider AG, Bellomo R. Acute kidney injury: new studies. Intensive Care Med. 2013; 39 (4): 569-571.